FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely nephrology, and may be used for administering ibandronate as an agent for low-metabolic bone disease in the patients suffering chronic renal insufficiency (CRI).
EFFECT: invention provides preventing developing incurable adynamic bone disease and transforming the low-metabolic bone disease into the high-metabolic bone disease thereby reducing the risks of fractures and a cardiovascular pathology, increasing the survival rate in the CRI patients.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR LOW-TURNOVER METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2491940C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH STAGE V CHRONIC KIDNEY DISEASE AT DIALYSIS STAGE | 2020 |
|
RU2753127C1 |
| METHOD FOR PREPARING A COMPLEX INFUSION PREPARATION AND USE THEREOF FOR CORRECTING HYPERPHOSPHATEMIA AND REDUCING VASCULAR IMPERMEABILITY IN PATIENTS WITH RENAL INSUFFICIENCY | 2020 |
|
RU2732754C1 |
| METHOD FOR NON-INVASIVE DIFFERENTIAL DIAGNOSIS OF PERIOCYTHOUS GREASES | 2021 |
|
RU2755931C1 |
| DIAGNOSTIC TECHNIQUE FOR STAGES OF CHRONIC KIDNEY DISEASE | 2013 |
|
RU2565394C2 |
| METHOD OF TREATING PATIENTS WITH ATROPHY OF ALVEOLAR PART OR DENTAL PROCESS IN OSTEOPENIC SYNDROME | 2008 |
|
RU2377012C1 |
| DIAGNOSTIC TECHNIQUE FOR CHRONIC AGGRESSIVE GENERALISED PERIODONTITIS | 2008 |
|
RU2415426C2 |
| METADICHOL-LIQUID AND GEL NANO-DRUGS | 2014 |
|
RU2736752C2 |
| EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC RENAL DISEASE | 2013 |
|
RU2566709C2 |
| METHOD FOR EARLY DIAGNOSIS OF ENDOTHELIAL RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2767701C1 |
